EndoT Overview

  • Founded
  • 1992
  • Status
  • Private
  • Employees
  • 220
  • Latest Deal Type
  • Debt - PPP
  • Latest Deal Amount
  • $1.77M
Latest Deal Amount
  • Investors
  • 1

EndoT General Information


Developer of endoscopy instruments designed to sell directly to endoscopy surgery centers in the United States. The company's instruments include endoscopic biopsy forceps, cytology brushes, polypectomy snares, injection needles, foreign body retrieval baskets and graspers, enabling physicians to treat their patients in an enhanced way and conduct successful surgeries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Medical Supplies
Primary Office
  • 15201 Roosevelt Boulevard
  • Suite 104
  • Clearwater, FL 33760
  • United States
+1 (727) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EndoT Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Debt - PPP 14-Apr-2020 $1.77M Completed Generating Revenue
4. Debt - General 02-Jun-2017 Completed Generating Revenue
3. Debt - General 23-Jun-2016 Completed Generating Revenue
2. Debt - General 12-Apr-2004 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view EndoT’s complete valuation and funding history, request access »

EndoT Patents

EndoT Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018301818-A1 Endoscopic snare net Pending 12-Jul-2017 000000000000
CA-3069450-A1 Endoscopic snare net Pending 12-Jul-2017 000000000000
US-20200163660-A1 Endoscopic snare net Pending 12-Jul-2017 000000000000
JP-2020526369-A Snare net for endoscopes Pending 12-Jul-2017 000000000000
EP-3651666-A1 Endoscopic snare net Pending 12-Jul-2017 A61B17/00234

EndoT Executive Team (6)

Name Title Board Seat Contact Info
Pete Sanchirico President & Chief Executive Officer
Tania Cefaratti Chief Financial Officer
Todd Adkisson Director, Engineering
Gary Jerge Director, Operations
Kevin Warren Director, Operations
You’re viewing 5 of 6 executive team members. Get the full list »

EndoT Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EndoT Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Coral Group Venture Capital Minority 000 0000 000000 0
To view EndoT’s complete investors history, request access »